Comparative in vitro activity of gemifloxacin, ciprofloxacin, levofloxacin and ofloxacin in a North American surveillance study

Clicks: 496
ID: 118301
1970
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Star

Ranked #3 of 48 articles by views in Diagnostic microbiology and infectious disease

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The in vitro activity of gemifloxacin, a new fluoroquinolone, was compared to three marketed fluoroquinolones; ciprofloxacin, levofloxacin and ofloxacin against over 4,000 recent clinical isolates covering 29 species isolated in the United States and Canada between 1997-1999. Based on MIC(90)s, gemi …
Reference Key
dj1970diagnosticcomparative Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hoban DJ, Bouchillon SK, Johnson JL, Zhanel GG, Butler DL, Miller LA, Poupard JA
Are you one of these authors? Claim your profile
Journal Diagnostic microbiology and infectious disease
Year 1970
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/11448564
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't united states / epidemiology Comparative Study microbial sensitivity tests gram-negative bacterial infections / epidemiology gram-negative bacterial infections / microbiology anti-infective agents / pharmacology* fluoroquinolones* gram-negative bacteria / drug effects* population surveillance* canada / epidemiology pmid:11448564 doi:10.1016/s0732-8893(01)00241-3 d j hoban s k bouchillon gemifloxacin surveillance study research group gemifloxacin gram-positive bacteria / drug effects* gram-positive bacterial infections / epidemiology gram-positive bacterial infections / microbiology naphthyridines / pharmacology*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.